Drug Induced Hematological Disorders: An Undiscussed Stigma

Abstract

Drug Induced Hematological Disorders (DIHD) are one among the most frequently encountered Adverse Drug Reactions (ADRs) among the patients using the systemic drug therapy. These unwanted and noxious incidents are often unnoticed or even neglected most of the time during the clinical practices. However, they largely affect the compliance of the patients with their therapy and subsequently affecting the therapeutic outcome of the drug regimen. The inception of the concept of Pharmacovigilance has largely enlightened on this neglected issue and raised the concern over several scientific sessions. However, this serious issue remained unaddressed clinically. These noxious conditions frequently provoke the adverse events or precipitate the underlying medical complications affecting the safety of the patients. The wise and vigilant use of certain risky medication capable of inducing such clinical conditions can significantly reduce these incidences. Thus, the utilization of the skills and the expertise knowledge of the clinical pharmacist can play a pivotal role in preventing and minimizing such events.